about
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.Dry Eye Disease Is Already Present in Hematological Patients Before Hematopoietic Stem Cell Transplantation.Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment.Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells.Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic SyndromesMeibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell TransplantationEyelid metrics assessment in patients with chronic ocular graft versus-host diseaseLiver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective StudyAcute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-termComparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examinationIntrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyClinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective studyRole of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature reviewOutcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Trans
P50
Q38774962-9252AA27-1CA1-478C-886D-5BE690ACA196Q40064942-233F533A-DFB2-42F8-A768-55CB11BAF32DQ40864239-CB5FCB9E-D021-4C88-97F5-03A65504D764Q53941832-262AF19D-168B-41D3-A8E8-6434F1DFF3EFQ56365008-BE9AC63F-1C34-4B1E-A009-47B3F7682B6CQ56395414-0D9627C0-1A97-4644-91AC-BDC8BD2687A9Q57472118-5B828091-FB6D-4E57-B5B8-59475B4FE62FQ91124711-2FDA22C3-0CBC-48DC-897F-BC366E5B4805Q91310430-92BB2B86-3353-4E58-B9BC-B06EE05D05A2Q91336235-CA0EC5BC-8536-4B42-A71A-0DDA6A79B404Q91556007-110446E2-7592-4B23-9518-72D76978AAF3Q91758330-FC141DF3-C318-4A45-981E-817F7B5EFBF1Q92519192-0CC89A12-2D75-484C-A207-0EFE436D5F08Q92540562-BF8C6846-89A3-41EC-BF2F-D0E84A426295
P50
description
investigador
@es
researcher
@en
name
Mariarosaria Sessa
@en
type
label
Mariarosaria Sessa
@en
prefLabel
Mariarosaria Sessa
@en
P31
P496
0000-0002-0519-7645